Oxford BioMedica (OXBDF) Stock Statistics & Valuation Metrics

Oxford BioMedica has a market cap or net worth of $422.64M. The enterprise value is $496.59M.

Oxford BioMedica has 105,997,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Oxford BioMedica’s return on equity (ROE) is -2.13 and return on invested capital (ROIC) is -84.99%.

The current PE Ratio of Oxford BioMedica is -1.35. Oxford BioMedica’s PEG ratio is >-0.01.

In the last 12 months, Oxford BioMedica had revenue of 89.54M and earned -157.49M in profits. Earnings per share was -1.63.

In the last 12 months, operating cash flow was -62.30M and capital expenditures -9.79M, giving a free cash flow of -72.09M billion.

Oxford BioMedica pays an annual dividend of ―, resulting in a dividend yield of ―

Oxford BioMedica upcoming earnings date is Apr 9, 2025, TBA Not Confirmed.

Oxford BioMedica as a current ratio of 3.19, with Debt / Equity ratio of 166.48%

In the past 12 months, Oxford BioMedica has paid -4.37M in taxes.

Oxford BioMedica EV to EBITDA ratio is -1.48, with an EV/FCF ratio of -5.74.

Oxford BioMedica has $81.41M in cash and marketable securities with £0.00 in debt, giving a net cash position of $28.90M billion.

Gross margin is 36.74%, with operating margin of -205.69%, and net profit margin of -175.89%.

The average price target for Oxford BioMedica is $8.65, which is 11.43% higher than the current price. The consensus rating is Moderate Buy